BioElectronics Corporation (BIEL)

OTCMKTS · Delayed Price · Currency is USD

0.0002

-0.0001 (-33.33%)

Mar 9, 2026, 3:07 PM EST

-33.33% (1Y)

Market Cap	7.41M
Revenue (ttm)	1.61M
Net Income (ttm)	-289.82K
Shares Out	24.71B
EPS (ttm)	-0.00
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,922,500
Average Volume	11,247,205
Open	0.0004
Previous Close	0.0003
Day's Range	0.0002 - 0.0004
52-Week Range	0.0001 - 0.0014
Beta	2.03
RSI	47.74
Earnings Date	n/a

About BioElectronics

BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. Its products include ActiPatch, a musculoskeletal pain therapy; Allay, a menstrual pain therapy; and Smart Insole, a heel pain therapy. The company also offers RecoveryRx, a medical device that provides pain management therapy for medical professionals; and HealFast, a drug-free therapy for horses, cats, and dogs that reduces swelling and pain, a... [Read more]

Industry Medical Devices

Sector Healthcare

Founded 2000

Employees 9

Stock Exchange OTCMKTS

Ticker Symbol BIEL

Full Company Profile

Financial Performance

In 2021, BioElectronics's revenue was $1.61 million, an increase of 94.01% compared to the previous year's $829,563. Losses were -$289,821, -75.01% less than in 2020.

Financial Statements

News

There is no news available yet.